Untitled Deck Flashcards

1
Q

What genes/changes cause Alagille Syndrome

A

JAG1 seq (83%), JAG1 del (11%), NOTCH2 (2.5%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the disease mechanism for Alagille?

A

JAG1 truncated protein product rendering it unable to bind to the cell membrane resulting in functional haploinsufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the proteins and gene locations in Alagille?

A

JAG1 = jagged 1 on 20p12.2, NOTCH2 = neurogenic locus notch homolog protein 2 on 1p12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical features of Alagille syndrome?

A

Bile duct paucity, cardiac defects (peripheral PS stenosis), cholestasis, skeletal abnormalities (butterfly vertebrae), eye (posterior embryotoxon), characteristic facial features, DD, growth failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Inheritance pattern for Alagille

A

autosomal dominant, but 50-70% de novo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the facial features of Alagille

A

prominent/broad forehead, deep-set eyes w/ moderate hypertelorism, pointed chin, saddle or straight nose w/ bulbous tip

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the primary gene, protein, and cytogenetic location for Brugada Syndrome

A

SCN5A, sodium channel protein type 5 subunit alpha, 3p22.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the inheritance pattern for Brugada?

A

autosomal dominant. Except for KCNE5 which is XLR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the disease mechanism for Brugada?

A

LOF mutations in SCN5A cause lack of expression of or acceleration in the inactivation of cardiac sodium channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a common clinical feature of Brugada Syndrome related to sleep?

A

Nocturnal agonal respiration

This refers to abnormal breathing patterns during sleep, often associated with serious medical conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In which leads are ST-segment abnormalities observed in Brugada Syndrome?

A

Leads V1-V3 on EKG

These leads are part of a standard 12-lead electrocardiogram used to assess heart function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a significant risk associated with Brugada Syndrome?

A

High risk of ventricular arrhythmias and sudden death

Ventricular arrhythmias can lead to life-threatening heart rhythms and sudden cardiac events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

At what stage of life does Brugada Syndrome primarily manifest?

A

Primarily in adulthood

Symptoms and complications typically arise in adult patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the mean age of sudden death in individuals with Brugada Syndrome?

A

40 years

This statistic highlights the serious nature of the condition and its impact on lifespan.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How may Brugada Syndrome present in infants?

A

As SIDS or sudden unexpected nocturnal death

SIDS stands for Sudden Infant Death Syndrome, which is a critical concern in pediatric populations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What family history may be relevant in cases of Brugada Syndrome?

A

Family history of sudden cardiac death

This can indicate a genetic predisposition to arrhythmias and related conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the management for Brugada syndrome?

A

implantable defibrillators (controversial in ASx patients)

18
Q

What medication is used to treat electrical storm in Brugada patients?

A

isoproterenol

19
Q

What circumstances should be avoided in Brugada syndrome?

A

fever, vagotonic agents, alpha-adrenergic agonists, beta-adrenergic antagonists, TCAs, 1st gen antihistamines, cocaine, class 1C antiarrhythmic drugs, Class 1A agents (procainamide, disopyramide)

20
Q

What are the genes/proteins and their locations that cause Cardio-Facio-Cutaneous (CFC) syndrome

A

BRAF1 (B-Raf proto-oncogene serine/threonine protein kinase) on 7q34, MAP2K1 on 15q22.31, MAP2K2 on 19q13.3 (mitogen-activated protein kinase 1 and 2), KRAS (GTPase Kras) on 12p12.2

21
Q

What is the inheritance pattern for CFC Syndrome

A

Autosomal dominant, but majority are de novo

22
Q

What is the disease mechanism for CFC syndrome

A

sustained activation of the Ras MAPK pathway downstream effectors: MEK and/or ERK

23
Q

What cardiac abnormalities are seen in CFC syndrome?

A

pulmonic stenosis, septal defects, hypertrophic cardiomyopathy, arrhythmias

24
Q

What neurologic manifestations are in CFC syndrome?

A

hypotonia, seizures, mild-severe ID

25
Q

What are the ectodermal findings seen in CFC syndrome?

A

xerosis, sparse/curly/wooly/brittle hair, dystrophic nails, nevi

26
Q

What clinical features are seen in CFC syndrome?

A

cardiac abnormalities, distinctive facial features, severe feeding issues, poor growth, relative macrocephaly, ectodermal findings, ID, hypotonia, seizures, eye abnormalities, a few w/ malignancy (ALL)

27
Q

What malignancy can be seen in CFC syndrome?

28
Q

What are the facial features of CFC syndrome?

A

relative macrocephaly, triangular facies, high forehead w/ bitemporal narrowing, low-set posteriorly rotated ears w/ thick helices, hypertelorism w/ down slanting palpebral fissures, epicanthal folds and ptosis, short nose w/ depressed nasal bridge w/ anteverted nares, high arched palate, cupid’s bow lips, deep philtrum, more coarse facial features and more dolichocephaly than noonan syndrome

29
Q

What is the percentage of CFC syndrome cases caused by each gene?

A

BRAF seq 75%, KRAS <2%, MAP2K1/2 together is 25%

30
Q

What genes/proteins and their locations that cause Hereditary Hemorrhagic Telangiectasis (HHT)?

A

ACVRL1 (activin A receptor type II-like kinase 1) on 12q13.3, ENG (endoglin) on 9q34.11, SMAD4 (Mothers against decapentaplegic homolog 4) on 10q11.22

31
Q

What percentage of HHT cases are caused by each gene?

A

ACVRL1 (52%) ENG (44%) SMAD4 (1%)

32
Q

What are the clinical characteristics of HHT?

A

epistaxis, mucocutaneous telangiectasias (lips, oral cavity, fingers, nose), visceral AVM (cerebral, pulmonary, GI, hepatic, spinal), 1st degree relative w/ HHT. At risk for colon cancer w/ SMAD4

33
Q

What additional screening is needed for HHT caused by SMAD4?

A

at risk for colon cancer. colonoscopy starting at 15yo, every 3 years w/o polyps or annually with an EGD if polyps are found

34
Q

What clinical tests are needed for HHT?

A

stool for occult blood, CBC (eval anemia or polycythemia), contrast echo for pulm AVM, Head MRI for cerebral AVM, doppler US vs CT/MRI for hepatic AVM, colon cancer screen for SMAD4 variants

35
Q

What is the inheritance pattern for HHT?

A

Autosomal dominant,

36
Q

What is the disease mechanism for HHT?

A

haploinsufficiency

37
Q

What genes/proteins and their locations cause Holt-Oram syndrome?

A

TBX5 (T-box transcription factor TBX5) on 12q24.1
SALL4 (Sal-like protein 4) on 20q13.2

38
Q

How is Holt-Oram syndrome inherited?

A

autosomal dominant, 85% de novo

39
Q

What is the disease mechanism for Holt-Oram syndrome?

A

TBX5 protein product is a transcription factor w/ important role in both cardiogenesis and limb development. TBX5 mutations lead to mutant TBX5 mRNAs that are rapidly degraded or to transcripts w/ diminished DNA binding resulting in HAPLOINSUFFICIENCY

40
Q

What are the clinical features of Holt-Oram syndrome?

A

upper limb defects (variable, carpal bone abnormalities are almost always present, radial ray defects, unilateral or bilateral),
CHD (most often ASD or VSD),
arrhythmia even w/o CHD

41
Q

What percentage of Holt-Oram syndrome is caused by each gene?

A

TBX5 seq (>70%)
TBX5 del/dup (<1%)
SALL4 (which can also cause Duane-radial ray syndrome and acro-renal-ocular syndrome which can look similar)